DSigDB Home
Search Gene
Collections
Browse Gene Sets
Download
Help

Gene Set: D4 : CTD - formoterol


Collection D4 : CTD
Chemical Name formoterol ( From PubChem : FORMOTEROL )
FDA NPC WHO Indian Australia China Traditional
Herbal
Clinical
Trail
ApprovedNotNotApprovedNotNotNotNot
Molecular
Weight
Hydrogen Bond
Donor Count
Hydrogen Bond
Acceptor Count
cLogP Lipinski Rule
344.405 g/mol 4 6 3.3231 True
Structure
InChI InChI=1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)/t13-,19+/m1/s1
InChIKey BPZSYCZIITTYBL-YJYMSZOUSA-N
Links

Gene (21 / 64)


⊖ Less

Source Type Unit Value Gene PMID Assay Other
CTDdecreases(expression)ACTA2
C012629
CTDdecreases(reaction)ACTA2
C012629
CTDaffects(binding)ADRB1
C012629
CTDincreases(activity)ADRB1
C012629
CTDincreases(abundance)ADRB1
C012629
CTDdecreases(reaction)ADRB1
C012629
CTDaffects(binding)ADRB2
C012629
CTDincreases(activity)ADRB2
C012629
CTDincreases(abundance)ADRB2
C012629
CTDincreases(phosphorylation)ADRB2
C012629
CTDaffects(binding)ADRB2
C012629
CTDdecreases(reaction)ADRB2
C012629
CTDincreases(phosphorylation)ADRB2
C012629
CTDaffects(binding)ADRB3
C012629
CTDincreases(activity)ADRB3
C012629
CTDincreases(abundance)ADRB3
C012629
CTDdecreases(reaction)ADRB3
C012629
CTDdecreases(expression)BCL2
C012629
CTDaffects(cotreatment)CCL5
C012629
CTDdecreases(secretion)CCL5
C012629
CTDdecreases(expression)CD44
C012629
CTDdecreases(reaction)CD44
C012629
CTDincreases(reaction)CD44
C012629
CTDaffects(cotreatment)CSF2
C012629
CTDdecreases(secretion)CSF2
C012629
CTDaffects(cotreatment)CXCL8
C012629
CTDdecreases(secretion)CXCL8
C012629
CTDaffects(cotreatment)FGF2
C012629
CTDdecreases(reaction)FGF2
C012629
CTDincreases(secretion)FGF2
C012629
CTDdecreases(expression)FGF2
C012629
CTDincreases(reaction)FGF2
C012629
CTDdecreases(activity)FGF2
C012629
CTDaffects(cotreatment)FN1
C012629
CTDdecreases(reaction)FN1
C012629
CTDincreases(secretion)FN1
C012629
CTDdecreases(expression)IL4
C012629
CTDdecreases(reaction)IL4
C012629
CTDincreases(reaction)IL4
C012629
CTDaffects(binding)MAPK1
C012629
CTDincreases(activity)MAPK1
C012629
CTDincreases(phosphorylation)MAPK1
C012629
CTDincreases(activity)MAPK1
C012629
CTDincreases(phosphorylation)MAPK1
C012629
CTDaffects(binding)MAPK3
C012629
CTDincreases(activity)MAPK3
C012629
CTDincreases(phosphorylation)MAPK3
C012629
CTDincreases(activity)MAPK3
C012629
CTDincreases(phosphorylation)MAPK3
C012629
CTDaffects(cotreatment)NR3C1
C012629
CTDaffects(localization)NR3C1
C012629
CTDdecreases(expression)RNASE3
C012629
CTDdecreases(reaction)SLC22A3
C012629
CTDincreases(uptake)SLC22A3
C012629
CTDdecreases(transport)SLC22A3
C012629
CTDincreases(response to substance)SLC22A3
C012629
CTDdecreases(expression)THY1
C012629
CTDdecreases(reaction)THY1
C012629
CTDincreases(reaction)THY1
C012629
PubChem PotencyuM6.310CYP2C19-GI(Protien) :
PubChem NoneuMCYP2C19-GI(Protien) :
PubChem PotencyuM1.995CYP2D6-GI(Protien) :
PubChem NoneuMCYP2D6-GI(Protien) :
PubChem PotencyuM0.001TSHR-GI(Protien) :
Download gene sets gmt, text, Detailed text
Contact us
Tan Lab , Mail Stop 8117
12801 East 17th Avenue
Division of Medical Oncology , Department of Medicine
University of Colorado School of Medicine
Aurora, CO 80045, USA

* Best viewed in the latest version of Chrome (42+), Safari (8+), IE (11+) or Firefox (35+).